TP53 and nonpapillary renal cell carcinoma: Since this method is currently unavailable to our team (i.e., RNA ISH requires different sample preparation [36]), we aimed to confirm the general TP53 expression pattern in tumor-control-metastasized ccRCC samples by the means of IHC.